Session Three-Four Panel Discussion: C-Peptide as Biomarker in Trials of T1D

Prof. Helen Colhoun

Professor Helen Colhoun (MB BCh BAO, MD, MFMHM FRCP (Ed)) is a Professor (AXA Chair) of Medical Info, Professor Helen Colhoun (MB BCh BAO, MD, MFMHM FRCP (Ed)) is a Professor (AXA Chair) of Medical Info

Stephen Karpen

Senior Director, Regulatory Affairs, Breakthrough T1D

Joseph Hedrick

Executive Director, Type 1 Diabetes Consortium, Critical Path Institute

Prof. Colin Mark Dayan

Professor of Clinical Diabetes and Metabolism, Cardiff University

Kimberly Collins

Senior Quantitative Medicine Scientist, Critical Path Institute

Christoph Tasto

Statistical Project Leader, Sanofi

Justin Penzenstadler, PharmD

Clinical Team Leader, Division of Diabetes, Lipid Disorders, and Obesity, FDA

Peter Senior

Professor, Alberta Diabetes Institute, University of Alberta